Sandra Milligan
President at ASPIRA WOMEN'S HEALTH INC.
Net worth: 575 421 $ as of 2024-03-30
Profile
Ms. Sandra Milligan is an Independent Director at Gossamer Bio, Inc. and a Head-Research & Development at Organon & Co. She is on the Board of Directors at Gossamer Bio, Inc. Ms. Milligan was previously employed as a Vice President-Regulatory Affairs by Genentech, Inc. She received her undergraduate degree from the University of California, Irvine, a graduate degree from Georgetown University Law Center and a doctorate degree from George Washington University School of Medicine & Health.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ORGANON & CO.
0.01% | 2023-05-03 | 28,599 ( 0.01% ) | 537 661 $ | 2024-03-30 |
GOSSAMER BIO, INC.
0.01% | 2023-11-14 | 32,000 ( 0.01% ) | 37 760 $ | 2024-03-30 |
Sandra Milligan active positions
| Companies | Position | Start |
|---|---|---|
| GOSSAMER BIO, INC. | Director/Board Member | 2021-06-09 |
| ASPIRA WOMEN'S HEALTH INC. | President | 2024-03-31 |
Former positions of Sandra Milligan
| Companies | Position | End |
|---|---|---|
| ORGANON & CO. | Chief Tech/Sci/R&D Officer | 2023-12-31 |
| MERCK & CO., INC. | Chief Tech/Sci/R&D Officer | 2020-03-31 |
Drug Information Association
 Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Director/Board Member | 2016-12-31 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 2014-12-31 |
| AMGEN INC. | Corporate Officer/Principal | 2011-12-31 |
Training of Sandra Milligan
| University of California, Irvine | Undergraduate Degree |
| Georgetown University Law Center | Graduate Degree |
| George Washington University School of Medicine & Health | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| AMGEN INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| ASPIRA WOMEN'S HEALTH INC. | Health Technology |
| GOSSAMER BIO, INC. | Health Technology |
| ORGANON & CO. | Health Technology |
| Private companies | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Drug Information Association
Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Commercial Services |
| The United States Army Medical Service Corps |
- Stock Market
- Insiders
- Sandra Milligan
